News
Roche to Invest $50B for U.S. Expansion, Including New Pharmaceutical Manufacturing Facilities
INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention to invest $50 billion in the United States over the next five years. The investment will include new and expanded life sciences facilities across the country,
WISH-TV on MSN1d
Roche to invest billions across the country, eyeing Indiana for new manufacturing facilityRoche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
With threats of tariffs hanging over the pharmaceutical industry, Switzerland’s Roche announced on Tuesday that it will ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...
With the threat of pharmaceutical tariffs hanging over the biopharmaceutical industry, Roche is the latest addition to a ...
Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback